Results 1 to 1 of 1
10-04-2013, 07:50 PM #1
Hospira Issues A Voluntary Nationwide Recall Of One Lot Of 1% Lidocaine HCL Injection
Hospira, Inc.(NYSE: HSP), announced today it has initiated a voluntary nationwide recall of one lot of 1% Lidocaine HCI Injection, USP, 10 mg/mL, 20 mL Multiple-dose Fliptop Vial, NDC 0409-4276-01 Lot 25-090-DK (the lot number may be followed 01 or 02).
This notice provided Budget101.com